The National Autonomous University of Mexico (UNAM) is among the top universities in the world, so it is no surprise that scientists Alberto Checa-Rojas and Sergio Manuel Encarnacion Guevara are in the lead to create the first medical device for early detection of cervical and uterine cancer. This will be used in a typical clinic without the need for sophisticated medical equipment and resources. As of today, there is no 100% effective way of detecting cervical/uterine cancer, so this device will be the first of its kind.
Currently, one of the most popular ways to find biomarkers for these types of cancers is analyzing serum from patients with the disease. However, this method offers very limited information on biomarkers due to its bio-molecular complexity. The Checa-Encarnacion team has solved this problem by developing a novel cell culture strategy that uses high technology proteomics to find 86 biomarkers; 23 for diagnosis in serum and 63 for cytological samples. This project is currently in phase 1 clinical trials. It is waiting for biomarker validation to eventually create a fast-use medical device for early detection and prevention.
As highlighted in last week's blog, Mexican scientists have actively shown innovation in Mexico, contrary to what big pharma thinks. Not only is innovation being encouraged by great scientists, but their work is relevant to the most current developments in the medical field.
To learn more about this and other innovative projects directly from their creators, sign up for BioPharma Mexico 2013 and join us this October 29th and 30th in Mexico City as we bring innovation and knowledge under the same roof.